ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
31
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,792
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease.
Author(s):
Carlos Becker
,
A Chrysostomou
Publication date:
2001-09-20
Journal:
The New England journal of medicine
Keywords:
Adult
,
Aged
,
Angiotensin-Converting Enzyme Inhibitors
,
therapeutic use
,
Chronic Disease
,
Drug Therapy, Combination
,
Enalapril
,
Female
,
Humans
,
Kidney Diseases
,
drug therapy
,
Male
,
Middle Aged
,
Mineralocorticoid Receptor Antagonists
,
Proteinuria
,
Spironolactone
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via free article)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
ChemSpider related publications
Author and article information
Journal
PubMed ID::
11565535
DOI::
10.1056/NEJM200109203451215
ScienceOpen disciplines:
Chemistry
Keywords:
Adult
,
Aged
,
Angiotensin-Converting Enzyme Inhibitors
,
therapeutic use
,
Chronic Disease
,
Drug Therapy, Combination
,
Enalapril
,
Female
,
Humans
,
Kidney Diseases
,
drug therapy
,
Male
,
Middle Aged
,
Mineralocorticoid Receptor Antagonists
,
Proteinuria
,
Spironolactone
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Adult
,
Aged
,
Angiotensin-Converting Enzyme Inhibitors
,
therapeutic use
,
Chronic Disease
,
Drug Therapy, Combination
,
Enalapril
,
Female
,
Humans
,
Kidney Diseases
,
drug therapy
,
Male
,
Middle Aged
,
Mineralocorticoid Receptor Antagonists
,
Proteinuria
,
Spironolactone
Comments
Comment on this article
Sign in to comment
scite_
Similar content
3,792
Effect of Spironolactone in Resistant Arterial Hypertension
Authors:
Jan Vaclavik
,
Richard Sedlák
,
Jiri Jarkovsky
…
Declining incidence of persistent proteinuria in type I (insulin-dependent) diabetic patients in Denmark.
Authors:
David Kreiner
,
T Deckert
,
K Borch-Johnsen
…
Identification of a new angiotensin-converting enzyme (ACE) inhibitor from Thai edible plants
Authors:
Pharkphoom Panichayupakaranant
,
Arunee Simaratanamongkol
,
Kaoru Umehara
…
See all similar
Cited by
31
Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies
Authors:
Annabelle Warren
,
Søren Knudsen
,
Mark E. Cooper
Effectiveness of Aldosterone Blockade in Patients With Diabetic Nephropathy
Authors:
Atsuhisa Sato
,
Koichi Hayashi
,
Mitsuhide Naruse
…
New pharmacological strategies for protecting kidney function in type 2 diabetes
Authors:
Marcel H A Muskiet
,
David C Wheeler
,
Hiddo J L Heerspink
See all cited by